GO:0051922 cholesterol sulfotransferase activity: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0051922 cholesterol sulfotransferase activity is a molecular function that catalyzes the transfer of a sulfate group from 3'-phosphoadenylyl sulfate (PAPS) to cholesterol, producing cholesterol sulfate and adenosine 3',5'-bisphosphate.
The reaction is a key step in epidermal and tracheal epithelial differentiation, and its activity increases during squamous differentiation.
SULT2B1 is the primary human enzyme responsible for cholesterol sulfotransferase activity, with two isoforms, SULT2B1a and SULT2B1b, showing tissue-specific expression.
Cholesterol sulfate, the product of this activity, is implicated in skin barrier function, prostate cancer progression, and metabolic regulation.
Genetic polymorphisms in SULT2B1 can alter enzyme activity and are associated with pathological conditions such as obesity and insulin resistance.
Studying this activity requires tools such as knockout and overexpression cell models, biochemical assays, and CRISPR screening to dissect its role in health and disease.

Description

Cholesterol sulfotransferase activity (GO:0051922) is a molecular function that catalyzes the sulfation of cholesterol, a reaction critical for the production of cholesterol sulfate, a bioactive lipid involved in diverse physiological processes. This activity was first characterized in epidermal keratinocytes, where it was linked to the multi-step process of differentiation. Since then, it has been detected in various tissues, including tracheal epithelial cells and prostate cancer cells, highlighting its broad biological significance. Researchers study this activity to understand its roles in skin barrier formation, lipid metabolism, and disease pathogenesis, particularly in cancer and metabolic disorders. The enzyme responsible, SULT2B1, is a member of the sulfotransferase family and utilizes 3'-phosphoadenylyl sulfate (PAPS) as a sulfate donor. Understanding the regulation and function of cholesterol sulfotransferase activity is essential for developing therapeutic strategies targeting related pathways.

cholesterol sulfotransferase activity At A Glance

GO ID GO:0051922
GO term cholesterol sulfotransferase activity
Ontology molecular_function
Synonym none
Major function Catalysis of the transfer of a sulfate group from PAPS to cholesterol, yielding cholesterol sulfate and adenosine 3',5'-bisphosphate
Reaction 3'-phosphoadenylyl sulfate + cholesterol = adenosine 3',5'-bisphosphate + cholesterol sulfate + H+
Primary enzyme SULT2B1 (isoforms SULT2B1a and SULT2B1b)
Tissue distribution Highly expressed in skin, prostate, and tracheal epithelium
Physiological role Involved in epidermal differentiation, skin barrier function, and lipid metabolism

What Is GO:0051922?

Cholesterol sulfotransferase activity (GO:0051922) is defined as the catalysis of the reaction: 3'-phosphoadenylyl sulfate + cholesterol = adenosine 3',5'-bisphosphate + cholesterol sulfate + H+. In simpler terms, it is the enzyme activity that attaches a sulfate group to cholesterol, forming cholesterol sulfate, a molecule with signaling and structural roles.

Why Is cholesterol sulfotransferase activity Important in Cell Biology?

Cholesterol sulfotransferase activity is crucial for the production of cholesterol sulfate, a molecule that plays key roles in epidermal differentiation, skin barrier integrity, and cellular signaling. Dysregulation of this activity has been linked to various pathological conditions, including obesity, insulin resistance, and cancer progression. For instance, inhibition of SULT2B1, the enzyme responsible for this activity, prevents obesity and insulin resistance in mice by regulating energy expenditure and intestinal lipid absorption. In prostate cancer, SULT2B1b modulates sensitivity to death receptor ligand TNFα, influencing tumor cell survival. Additionally, genetic polymorphisms in SULT2B1 can affect enzyme activity and contribute to disease susceptibility. Therefore, understanding cholesterol sulfotransferase activity is essential for developing targeted therapies and diagnostic tools for metabolic and oncological diseases.
Critical for epidermal differentiation and skin barrier formation.
Involved in the regulation of energy expenditure and lipid absorption.
Modulates sensitivity to TNFα-induced cell death in prostate cancer.
Genetic polymorphisms in SULT2B1 affect enzyme activity and disease risk.
Plays a role in acetaminophen-induced liver injury in mice.
Cholesterol sulfate, the product, is a bioactive lipid with signaling functions.
Potential therapeutic target for obesity and insulin resistance.
Biomarker for squamous differentiation in epithelial cells.
Implicated in the pathophysiology of castration-resistant prostate cancer.
Provides a model for studying sulfotransferase-mediated lipid metabolism.

Molecular Mechanism of cholesterol sulfotransferase activity

Substrate Binding and Catalysis
In simple terms: The enzyme grabs cholesterol and a sulfate donor, then transfers the sulfate group.
Cholesterol sulfotransferase activity catalyzes the transfer of a sulfate group from 3'-phosphoadenylyl sulfate (PAPS) to the 3-hydroxyl group of cholesterol, forming cholesterol sulfate and adenosine 3',5'-bisphosphate. The enzyme SULT2B1b, a member of the sulfotransferase family, is the primary catalyst in humans. This reaction is essential for the production of cholesterol sulfate, which accumulates during squamous differentiation.
Cofactor Requirements
In simple terms: The enzyme needs PAPS as a sulfate donor to work.
The catalytic mechanism requires 3'-phosphoadenylyl sulfate (PAPS) as the sulfate donor, which is converted to adenosine 3',5'-bisphosphate (PAP) in the process. This cofactor dependency is characteristic of sulfotransferases, and the availability of PAPS can influence enzyme activity.
Enzyme Isoforms and Tissue Specificity
In simple terms: Different versions of the enzyme are found in different tissues.
In humans, SULT2B1 exists as two isoforms, SULT2B1a and SULT2B1b, which differ in their N-terminal sequences and tissue distribution. SULT2B1b is predominantly expressed in prostate and skin, while SULT2B1a is found in other tissues. Both isoforms exhibit cholesterol sulfotransferase activity, but their regulation and substrate specificity may vary.
Regulation by Retinoic Acid and Differentiation
In simple terms: The activity can be turned up or down by signals that control cell specialization.
Cholesterol sulfotransferase activity increases during in vitro squamous differentiation of rabbit tracheal epithelial cells, and this increase is inhibited by retinoic acid. Similarly, in human epidermal keratinocytes, the activity is upregulated in relation to the multi-step process of differentiation. These findings suggest that the enzyme is tightly regulated during epithelial differentiation.
Kinetic Properties and Assays
In simple terms: Scientists measure how fast the enzyme works using specific tests.
Cholesterol sulfotransferase activity can be assayed by measuring the formation of cholesterol sulfate from cholesterol and PAPS using radiolabeled substrates or mass spectrometry. The enzyme from newborn mouse epidermis has been partially characterized, showing optimal activity at neutral pH and dependence on divalent cations. These assays are crucial for studying enzyme kinetics and inhibitor screening.

Key Genes Involved in GO:0051922 cholesterol sulfotransferase activity

The following genes and proteins are directly involved in or regulate cholesterol sulfotransferase activity (GO:0051922).
GeneMajor RoleResearch Relevance
SULT2B1Primary enzyme catalyzing cholesterol sulfation; isoforms SULT2B1a and SULT2B1bTarget for metabolic and cancer studies; genetic polymorphisms affect activity
SULT2B1bIsoform predominantly expressed in prostate and skin; modulates TNFα sensitivityStudied in castration-resistant prostate cancer
SULT2B1aIsoform expressed in other tissues; cholesterol sulfotransferase activityLess characterized; potential role in lipid metabolism
PAPSS1Synthesizes PAPS, the sulfate donorIndirect regulator of sulfation reactions
PAPSS2Synthesizes PAPS, the sulfate donorIndirect regulator of sulfation reactions
CholesterolSubstrate for the reactionLipid precursor; levels affect enzyme activity
Cholesterol sulfateProduct of the reaction; bioactive lipidMarker of differentiation; signaling molecule
Retinoic acidInhibits cholesterol sulfotransferase activity during differentiationUsed to study regulation of squamous differentiation
TNFαDeath receptor ligand; sensitivity modulated by SULT2B1bStudied in prostate cancer cell death
AcetaminophenInduces liver injury; role of cholesterol sulfotransferaseModel for drug-induced hepatotoxicity
KeratinocytesCell type where activity was first linked to differentiationModel for epidermal differentiation
Tracheal epithelial cellsCell type showing increased activity during squamous differentiationModel for respiratory epithelial differentiation
Mouse epidermisSource of enzyme for biochemical characterizationModel for skin studies
Prostate cancer cellsSULT2B1b expression affects TNFα sensitivityModel for castration-resistant prostate cancer
Intestinal cellsSULT2B1 inhibition affects lipid absorptionModel for obesity and insulin resistance
Liver cellsCholesterol sulfotransferase involved in acetaminophen-induced injuryModel for hepatotoxicity
AdipocytesSULT2B1 inhibition regulates energy expenditureModel for metabolic studies
Sulfotransferase familySULT2B1 belongs to this familyComparative studies of sulfation

How Is cholesterol sulfotransferase activity Regulated?

Cholesterol sulfotransferase activity is regulated at multiple levels. During squamous differentiation, its activity increases in epidermal keratinocytes and tracheal epithelial cells, and this upregulation is inhibited by retinoic acid. The enzyme SULT2B1 is subject to genetic polymorphisms that can alter its catalytic activity and are associated with pathological conditions such as obesity and insulin resistance. Additionally, inhibition of SULT2B1 prevents obesity and insulin resistance by regulating energy expenditure and intestinal lipid absorption, indicating that the activity is modulated in response to metabolic status. In prostate cancer, SULT2B1b expression modulates sensitivity to TNFα, suggesting that the activity can influence cell death pathways. Furthermore, cholesterol sulfotransferase activity is involved in acetaminophen-induced liver injury, where its regulation may affect drug toxicity.

cholesterol sulfotransferase activity and Human Disease

GeneDisease / BiologyPotential Experimental Model
SULT2B1Obesity and insulin resistanceKnockout mouse or cell model with SULT2B1 inhibition
SULT2B1bCastration-resistant prostate cancerProstate cancer cell lines with SULT2B1b knockdown or overexpression
SULT2B1Acetaminophen-induced liver injuryMouse model with SULT2B1 modulation
SULT2B1Genetic polymorphisms affecting enzyme activityPatient-derived cells or genotyping studies
SULT2B1Skin differentiation disordersKeratinocyte differentiation models
Cholesterol Sulfotransferase Activity in Metabolic Disorders
Inhibition of SULT2B1, the enzyme responsible for cholesterol sulfotransferase activity, prevents obesity and insulin resistance in mice by regulating energy expenditure and intestinal lipid absorption. This suggests that targeting this activity could be a therapeutic strategy for metabolic diseases. Genetic polymorphisms in SULT2B1 that affect enzyme activity may also contribute to interindividual variability in metabolic risk.
Role in Prostate Cancer
SULT2B1b, an isoform with cholesterol sulfotransferase activity, modulates sensitivity to death receptor ligand TNFα in castration-resistant prostate cancer. This indicates that the activity may influence tumor cell survival and could be a potential target for prostate cancer therapy.
Implications in Liver Injury
Cholesterol sulfotransferase activity has been implicated in acetaminophen-induced liver injury in mice, where its regulation may affect the severity of hepatotoxicity. This highlights the importance of understanding this activity in drug metabolism and liver disease.
Skin Barrier and Differentiation Disorders
Cholesterol sulfotransferase activity is critical for epidermal differentiation and skin barrier formation, and its dysregulation may contribute to skin disorders characterized by abnormal differentiation. The product, cholesterol sulfate, is a marker of squamous differentiation and plays a role in skin barrier function.

From cholesterol sulfotransferase activity-Related Genes to Experimental Models

Research QuestionSuitable Model
Does SULT2B1 knockout affect cholesterol sulfate levels?SULT2B1 knockout cell line (e.g., HEK293 or keratinocytes)
How do point mutations in SULT2B1 affect enzyme activity?Point-mutation knock-in cell lines expressing mutant SULT2B1
Can overexpression of SULT2B1b increase cholesterol sulfate production?SULT2B1b overexpression cell model
What is the role of SULT2B1 in obesity?SULT2B1 knockout mouse model
How does SULT2B1b modulate TNFα sensitivity?Prostate cancer cells with SULT2B1b knockdown or overexpression
Does SULT2B1 inhibition protect against acetaminophen-induced liver injury?Mouse model with SULT2B1 inhibitor

How to Study the cholesterol sulfotransferase activity Process

MethodWhat It MeasuresTypical Application
Radiolabeled substrate assayEnzyme activity using 14C-cholesterol and PAPSKinetic studies and inhibitor screening
Mass spectrometryCholesterol sulfate levelsQuantification in cells and tissues
RNA-seqSULT2B1 mRNA expressionTissue-specific expression profiling
CRISPR knockout screenGenes affecting cholesterol sulfate productionDiscovery of regulatory pathways
Western blotSULT2B1 protein levelsValidation of expression changes
ImmunohistochemistryTissue distribution of SULT2B1Localization in skin and prostate
LipidomicsCholesterol sulfate and related lipidsMetabolic profiling
Reporter assaysPromoter activity of SULT2B1Regulation by retinoic acid
Biochemical Assays for Cholesterol Sulfotransferase Activity
Cholesterol sulfotransferase activity can be measured using radiolabeled cholesterol and PAPS, followed by separation of products by thin-layer chromatography or high-performance liquid chromatography. Alternatively, mass spectrometry-based methods can quantify cholesterol sulfate formation. These assays are essential for determining enzyme kinetics and screening inhibitors.
Gene Expression Analysis
RNA-seq or quantitative PCR can be used to measure SULT2B1 mRNA levels in different tissues or under various conditions. This helps correlate enzyme expression with activity and disease states.
CRISPR Screening for Regulators
Genome-wide CRISPR knockout screens can identify genes that regulate cholesterol sulfotransferase activity or cholesterol sulfate levels. Such screens can uncover novel pathways and therapeutic targets.
Proteomic and Lipidomic Profiling
Proteomics can quantify SULT2B1 protein levels, while lipidomics can measure cholesterol sulfate and other lipids. These approaches provide a comprehensive view of the metabolic impact of the activity.

How CRISPR Can Be Used to Study GO:0051922 cholesterol sulfotransferase activity

Knockout

CRISPR knockout of SULT2B1 can completely abolish cholesterol sulfotransferase activity, allowing researchers to study its loss-of-function effects on cholesterol sulfate production, differentiation, and disease models. For example, SULT2B1 knockout mice are protected from obesity and insulin resistance.

Point Mutation

Introducing point mutations in SULT2B1 that mimic human polymorphisms can help determine how specific amino acid changes affect enzyme activity and substrate specificity. Such models are valuable for understanding genetic contributions to disease.

Knock-in

Knock-in of tagged SULT2B1 (e.g., FLAG or GFP) allows for tracking enzyme localization and interaction partners in live cells. This can reveal dynamic regulation of cholesterol sulfotransferase activity.

Overexpression

Overexpression of SULT2B1b in prostate cancer cells increases cholesterol sulfotransferase activity and modulates sensitivity to TNFα, providing a model to study its role in tumor survival. Overexpression in other cell types can also elucidate its metabolic effects.

How EDITGENE Supports cholesterol sulfotransferase activity Research

Researchers studying cholesterol sulfotransferase activity-related genes often need to determine whether a candidate gene is causally involved in the regulation of cholesterol sulfate production, differentiation, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for cholesterol sulfotransferase activity research.

Frequently Asked Questions About cholesterol sulfotransferase activity

Cholesterol sulfotransferase activity (GO:0051922) is a molecular function that catalyzes the transfer of a sulfate group from 3'-phosphoadenylyl sulfate to cholesterol, producing cholesterol sulfate and adenosine 3',5'-bisphosphate.
The primary gene is SULT2B1, which encodes the enzyme with two isoforms, SULT2B1a and SULT2B1b. Other genes like PAPSS1 and PAPSS2 are involved in synthesizing the sulfate donor PAPS.
SULT2B1, a member of the sulfotransferase family, is the main enzyme responsible for cholesterol sulfotransferase activity in humans.
The product is cholesterol sulfate, a bioactive lipid involved in skin barrier function and cell signaling.
It is regulated during differentiation, inhibited by retinoic acid, and influenced by genetic polymorphisms in SULT2B1.
It is associated with obesity, insulin resistance, prostate cancer, and acetaminophen-induced liver injury.
You can use biochemical assays with radiolabeled substrates, mass spectrometry, and CRISPR-based knockout or overexpression models.
SULT2B1b modulates sensitivity to TNFα in castration-resistant prostate cancer, affecting cell death pathways.
Inhibition of SULT2B1 prevents obesity and insulin resistance in mice, suggesting it is a potential therapeutic target.
SULT2B1 has two isoforms, SULT2B1a and SULT2B1b, which differ in tissue distribution and regulation.

Conclusion

Cholesterol sulfotransferase activity (GO:0051922) is a critical molecular function that produces cholesterol sulfate, a lipid with diverse roles in differentiation, metabolism, and disease. The enzyme SULT2B1 and its isoforms are central to this activity, and their dysregulation has been linked to obesity, insulin resistance, prostate cancer, and liver injury. Understanding the regulation and function of this activity provides insights into basic biology and potential therapeutic targets. Continued research using advanced CRISPR models and biochemical assays will further elucidate its mechanisms and clinical relevance.

References

  1. 1. Jetten AM et al.. 1989. Increased cholesterol sulfate and cholesterol sulfotransferase activity in relation to the multi-step process of differentiation in human epidermal keratinocytes.. J Invest Dermatol 92(2):203-9 PMID: 2465352
  2. 2. Wang J et al.. 2025. Inhibition of sulfotransferase SULT2B1 prevents obesity and insulin resistance by regulating energy expenditure and intestinal lipid absorption.. J Biol Chem 301(7):110327 PMID: 40456448
  3. 3. Rearick JI et al.. 1987. Increase in cholesterol sulfotransferase activity during in vitro squamous differentiation of rabbit tracheal epithelial cells and its inhibition by retinoic acid.. J Biol Chem 262(27):13069-74 PMID: 3477542
  4. 4. Epstein EH Jr et al.. 1984. Cholesterol sulfotransferase of newborn mouse epidermis.. J Invest Dermatol 83(5):332-5 PMID: 6238102
  5. 5. Alherz FA. 2024. Human sulfotransferase SULT2B1 physiological role and the impact of genetic polymorphism on enzyme activity and pathological conditions.. Front Genet 15:1464243 PMID: 39280099
  6. 6. Vickman RE et al.. 2019. Cholesterol Sulfotransferase SULT2B1b Modulates Sensitivity to Death Receptor Ligand TNFα in Castration-Resistant Prostate Cancer.. Mol Cancer Res 17(6):1253-1263 PMID: 30824526
  7. 7. Gimpl G. 2010. Cholesterol-protein interaction: methods and cholesterol reporter molecules.. Subcell Biochem 51:1-45 PMID: 20213539
  8. 8. An Y et al.. 2019. An Unexpected Role of Cholesterol Sulfotransferase and its Regulation in Sensitizing Mice to Acetaminophen-Induced Liver Injury.. Mol Pharmacol 95(6):597-605 PMID: 30944208
Contact Us
*
*
*
*
How did you hear about us: